COVID-19 Testing Kits Market: Information by Product (RT-PCR Assay Kits), Specimen Type (Nasopharyngeal Swab), End-User (Hospitals),and Region—Forecast till 2029

Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis:  COVID-19 Testing Kits Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   The Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

3.6       Technological Overview

3.7       Top investment pockets

3.7       Impact of COVID-19 on COVID-19 Testing Kits Market

4          Product Overview

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       RT-PCR Assay Kits

4.2.1   Market Size & Forecast (Value)

4.3       Immunoassay Test Strips/Cassettes

4.3.1   Market Size & Forecast (Value)

5          Specimen Type Overview

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Nasopharyngeal Swab

5.2.1   Market Size & Forecast (Value)

5.3       Oropharyngeal Swab

5.3.1   Market Size & Forecast (Value)

5.4       Nasal Swab

5.4.1   Market Size & Forecast (Value)

5.5       Others

5.5.1   Market Size & Forecast (Value)

6          End User Overview

6.1       Introduction

6.1.1   Market Size & Forecast (Value)

6.2       Hospitals

6.2.1   Market Size & Forecast (Value)

6.3       Diagnostic Centers

6.3.1   Market Size & Forecast (Value)

6.4       Others

6.4.1   Market Size & Forecast (Value)

7          Regional Overview

7.1      Introduction

7.1.1   Market Size & Forecast (Value)

7.2      North America

7.2.1   North America

7.2.1.1      The U.S.

7.2.1.1.1         By Product

7.2.1.1.2         By Specimen Type

7.2.1.2      Canada

7.2.1.2.1         By Product

7.2.1.2.2         By Specimen Type

7.2.1.3      Mexico

7.2.1.3.1         By Product

7.2.1.3.2         By Specimen Type

7.2.2   Central and South America and the Caribbean

7.2.2.1      By Product

7.2.2.2      By Specimen Type

7.2.2.2.1   Brazil

7.2.2.2.1.1      By Product

7.2.2.2.1.2      By Specimen Type

7.2.2.2.2   Argentina

7.2.2.2.2.1      By Product

7.2.2.2.2.2      By Specimen Type

7.2.2.2.3   The Rest of Central and South America and the Caribbean

7.2.2.2.3.1      By Product

7.2.2.2.3.2      By Specimen Type

7.3      Europe

7.3.1   Market Size & Forecast (Value)

7.3.2   Western Europe

7.3.2.1      The U.K.

7.3.2.1.1         By Product

7.3.2.1.2         By Specimen Type

7.3.2.2      Germany

7.3.2.2.1         By Product

7.3.2.2.2         By Specimen Type

7.3.2.3      France

7.3.2.3.1         By Product

7.3.2.3.2         By Specimen Type

7.3.2.4      Spain

7.3.2.4.1         By Product

7.3.2.4.2         By Specimen Type

7.3.2.5      Italy

7.3.2.5.1         By Product

7.3.2.5.2         By Specimen Type

7.3.2.6      The Rest of Western Europe

7.3.2.6.1         By Product

7.3.2.6.2         By Specimen Type

7.3.3   Eastern Europe

7.3.3.1  By Product

7.3.3.2  By Specimen Type

7.3.4   The Rest of Europe

7.3.4.1  By Product

7.3.4.2  By Specimen Type

7.4      Asia-Pacific

7.4.1   Market Size & Forecast (Value)

7.4.2   Japan

7.4.2.1            By Product

7.4.2.2            By Specimen Type

7.4.3   China

7.4.3.1            By Product

7.4.3.1            By Specimen Type

7.4.4   Australia

7.4.4.1            By Product

7.4.4.2            By Specimen Type

7.4.5   India

7.4.5.1            By Product

7.4.5.2            By Specimen Type

7.4.6   South Korea

7.4.6.1            By Product

7.4.6.2            By Specimen Type

7.4.7   The Rest of Asia-Pacific

7.4.7.1            By Product

7.4.7.2            By Specimen Type

7.7      The Middle East & Africa

7.7.1   The Middle East

7.7.1.1            Market Size & Forecast (Value)

7.7.1.2            Saudi Arabia

7.7.1.2.1         By Product

7.7.7.2.2         By Specimen Type

7.7.1.3            The UAE

7.7.1.3.1         By Product

7.7.1.3.2         By Specimen Type

7.7.1.4            Qatar

7.7.1.4.1         By Product

7.7.1.4.2         By Specimen Type

7.7.2   The Africa

7.7.2.1            Market Size & Forecast (Value)

8          Company Profile

8.1      Abbott Laboratories

8.1.1   Company Overview

8.1.2   Financial Performance

8.1.3   Recent Developments

8.1.4   Product Portfolio

8.2      BGI

8.2.1   Company Overview

8.2.2   Financial Performance

8.2.3   Recent Developments

8.2.4   Product Portfolio

8.3      BioFire Diagnostics

8.3.1   Company Overview

8.3.2   Financial Performance

8.3.3   Recent Developments

8.3.4   Product Portfolio

8.4      Cepheid

8.4.1   Company Overview

8.4.2   Financial Performance

8.4.3   Recent Developments

8.4.4   Product Portfolio

8.5      F. Hoffmann-La Roche

8.5.1   Company Overview

8.5.2   Financial Performance

8.5.3   Recent Developments

8.5.4   Product Portfolio

8.6      GenMark Diagnostics

8.6.1   Company Overview

8.6.2   Financial Performance

8.6.3   Recent Developments

8.6.4   Product Portfolio

8.7      Guangzhou Wondfo Biotech

8.7.1   Company Overview

8.7.2   Financial Performance

8.7.3   Recent Developments

8.7.4   Product Portfolio

8.8      Mylab Discovery Solutions

8.8.1   Company Overview

8.8.2   Financial Performance

8.8.3   Recent Developments

8.8.4   Product Portfolio

8.9      Qiagen

8.9.1   Company Overview

8.9.2   Financial Performance

8.9.3   Recent Developments

8.9.4   Product Portfolio

8.10    Quidel Corporation

8.10.1 Company Overview

8.10.2 Financial Performance

8.10.3 Recent Developments

8.10.4 Product Portfolio

8.11    Randox Laboratories

8.11.1 Company Overview

8.11.2 Financial Performance

8.11.3 Recent Developments

8.11.4 Product Portfolio

8.12    SD Biosensor

8.12.1 Company Overview

8.12.2 Financial Performance

8.12.3 Recent Developments

8.12.4 Product Portfolio

8.13    Seegene

8.13.1 Company Overview

8.13.2 Financial Performance

8.13.3 Recent Developments

8.13.4 Product Portfolio

8.14    Shenzhen Bioeasy Biotechnology

8.14.1 Company Overview

8.14.2 Financial Performance

8.14.3 Recent Developments

8.14.4 Product Portfolio

8.15    Thermo Fisher Scientific.

8.15.1 Company Overview

8.15.2 Financial Performance

8.15.3 Recent Developments

8.15.4 Product Portfolio

9          Conclusion & Recommendations

10        Acronyms & Abbreviations

Report Description Download Sample

Copyright . All rights Reserved By Straits Research